Thinking out loud, page-13

I am not sure if you guys are not researched enough or just turning a blind eye to the facts.
We have a POC hand held troponin test already approved in Europe and awaiting FDA approval for use in the USA which is expected shortly. http://www.meritaspoc.com/Products/Troponin-I/

• First and only true POC test able to provide results consistent with the Third Universal Definition of Myocardial Infarction
• < 10% CV at the 99th percentile Upper Reference Limit (URL)
• Enables compliance to the NACB Troponin recommended turnaround time of 30 minutes, with test results delivered in just 15 minutes
• Top laboratory quality at the POC

- See more at: http://www.meritaspoc.com/Products/Troponin-I/#sthash.ObViTpMC.dpuf.
They certainly didn't need Anteo.
Trinity the company behind the Merita POC only had revenues of 4 million usd last quarter.
3% of that is about 150,000 usd in revenues

According to Barrons, the whole POC tropinon market in the US is 350 million.
The whole market.
If Philips managed in time a quarter of that market and somehow earned 100 million, Anteo, getting 3% commission will make 3 million a year.
Still not enough to be cash flow positive.
So they definitely need to be included in all Philips POC test cartridges
From my research, (yes, I can look up google), There is much more to a successful POC test than just sensitivity. http://www.mayomedicallaboratories....ranscripts/2010/2010-10a-troponin/10a-15.html

Also from other sources.
An ideal point-of-care cardiac biomarker for use in primary care should have near 100% sensitivity and be able to exclude AMI and possibly also UA with high accuracy. The purpose would mainly be to reduce the number of emergency referrals.
And
Among cardiologists, Dr. Christenson has seen the gamut of opinion about increasingly sensitive troponin assays. “Some are very excited about it—mostly folks that know a lot about cardiac markers. Some are waiting to see, and others think it’s all a pain in the neck and why are you doing this anyway. They say, ‘Troponin used to be a good test until you guys screwed it up.’ There are always nihilists and enthusiasts. I guess I would call myself enthusiastic.”

I feel Anteo raised more capital, despite them having 5 million in the bank and having already raised $5.5 million @12.5 cents in Dec 2013 precisely to fund non core opportunities such as Anteo Energy

"These funds provide the company with the financial flexibility to expedite the development and commercialisation of products, made possible by the filing of two new patents, which complement the existing Mix&Go product portfolio from 7 years to 3 years. These new patents will expand the protected areas of application to bioseparations, drug screening, drug delivery and areas outside the health care industry and the funds bring revenues from these areas much closer."

They just don't think that they will be cash flow positive anytime soon.